• iPremom raised EUR 15 million in a seed round backed by Amadeus Capital Partners, Asabys Partners, APEX Ventures.
• Valencia-based iPremom develops molecular diagnostics to predict first-trimester pregnancy complications using a single blood test.
• Proceeds fund clinical validation, commercial rollout of the MaiRa platform, regulatory approvals in the EU, US.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. APEX Ventures GmbH published the original content used to generate this news brief on September 02, 2026, and is solely responsible for the information contained therein.